老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ReShape Lifesciences, Inc.

2.50
-0.1200-4.58%
盘后：2.500.00000.00%19:50 EDT
成交量：15.02万
成交额：37.58万
市值：596.49万
市盈率：-0.01
高：2.55
开：2.55
低：2.45
收：2.62
数据加载中...
总览公司新闻公告
2022/04/14

重要事件披露

8-K - Current report
2022/04/08

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/28

重要事件披露

8-K - Current report
2022/03/22

重要事件披露

8-K/A [Amend] - Current report
2022/03/17

重要事件披露

8-K - Current report
2022/02/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/12

重要事件披露

8-K - Current report
2021/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/09/15

SEC问询函

CORRESP [Cover] - Correspondence
2021/08/16

重要事件披露

8-K - Current report
2021/08/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/19

重要事件披露

8-K - Current report
2021/07/02

重要事件披露

8-K - Current report
2021/06/30

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/30

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/06/25

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/06/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/06/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/06/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
更多